SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-18-048214
Filing Date
2018-09-06
Accepted
2018-09-06 07:05:20
Documents
4
Period of Report
2018-09-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv502397_8k.htm 8-K 24158
2 EXHIBIT 10.1 tv502397_ex10-1.htm EX-10.1 78864
3 EXHIBIT 99.1 tv502397_ex99-1.htm EX-99.1 18837
4 GRAPHIC image_001.jpg GRAPHIC 5598
  Complete submission text file 0001144204-18-048214.txt   131246
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 617 DETROIT STREET, SUITE 100 ANN ARBOR MI 48104 (734) 332-7800
Synthetic Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

IRS No.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12584 | Film No.: 181056644
SIC: 2834 Pharmaceutical Preparations